Загрузка...
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
PURPOSE: Androgen deprivation therapy is associated with fracture risk in men with prostate cancer. We assessed the effects of toremifene, a selective estrogen receptor modulator, on fracture incidence in men receiving androgen deprivation therapy during a 2-year period. MATERIALS AND METHODS: In th...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047407/ https://ncbi.nlm.nih.gov/pubmed/20723926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.06.022 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|